Global Information
회사소개 | 문의 | 비교리스트

의료 용도의 3D 프린팅

3D Printing for Healthcare Applications

리서치사 Frost & Sullivan
발행일 2016년 12월 상품 코드 422219
페이지 정보 영문 90 Pages
가격
US $ 4,950 ₩ 5,982,000 Web Access (Regional License) help
리서치사의 웹사이트에 로그인할 수 있는 패스워드가 발급되며, PDF를 다운로드 받는 형태로 제공됩니다. 동일 국가 내에 있는 사업장의 모든 분들이 이용할 수 있는 라이선스이며, 이용 인원수 제한은 없습니다. 텍스트 등의 PDF 내용 편집은 불가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


의료 용도의 3D 프린팅 3D Printing for Healthcare Applications
발행일 : 2016년 12월 페이지 정보 : 영문 90 Pages

의료 부문의 3D 프린팅(3DP) 시장 기회에 대해 조사했으며, 시장 및 기술의 정의와 개요, 3DP의 의료 부문에 대한 영향력, 주요 뉴스, 도입이 진행되는 분야, 주요 기업의 활동, 의약품 부문의 잠재성, 시장 기회 분석과 성공·성장을 위한 필수요건 등을 정리하여 전해드립니다.

제1장 개요

제2장 개요·정의

  • 3D 프린팅 vs 기존형 제조업
  • 크라우드소싱과 3DP
  • 변화를 주도하는 크라우드소서
  • 매스커스터마이제이션과 3DP

제3장 3DP 기술 개요

  • 주요 3DP 기술
  • 3DP 기술 비교 분석

제4장 의료 부문용 3DP 분석

  • 의료·산업 부문을 비롯한 3DP의 광범위한 산업 분야에 대한 영향력
  • 3DP : 의료 부문의 혁신을 위한 플랫폼
  • 의료 산업의 최근 3DP 관련 뉴스
  • 3DP 관련 혁신의 활발한 도입이 진행되는 분야
    • 보철재·골이식편·치과보철재·혈관 조직

제5장 의료 부문의 3DP 컴피턴시(Competency)

  • 적층 가공의 비지니스 모델 : 3D 프린터 제조업체
  • 적층 가공의 비지니스 모델 : 재료 프로바이더
  • 적층 가공의 비지니스 모델 : 서비스 프로바이더
  • 3DP 기술 비교 분석
  • 기업 개요 : Stratasys
    • 치과 부문의 활동
    • 프린터 이용 : 사례 연구
    • 의료 부문의 활동
  • 기업 개요 : 3D Systems
    • 의료 부문의 활동
    • 프린터 이용

제6장 잠재적 용도 분석 : 의약품

  • 3DP : 의약품 산업의 주요 영역
    • 질환 치료·약물전달 프로세스
      • 의약품 요건
      • 밸류체인에 대한 영향
      • 제조 기술의 혁신
      • 의약품 혁신에서 프린터의 영향
      • 태블릿 배합 종류와 요건
      • 사례 연구 : Aprecia Pharmaceuticals
      • 사례 연구 : Organovo
    • 의약품 사업의 운영 모델
      • 3DP : CMO의 주요 주목점
      • 의약품 R&D에 대한 영향
      • 의약품 전체의 이점
      • 현재 3DP 실장 전략
      • 대형 사업자에 의한 현재 3DP 실장 전략
    • 의약품 공급망
  • 신흥 시장에 대한 영향
  • 법규제 환경
  • 촉진요인과 장벽
  • 성장 촉진요인 해설
  • 성장 저해요인 해설
  • 디지털 제작 : 신흥 국가의 의약품 접근성에 대한 잠재적 영향
  • 전진을 위한 전략적 제안

제7장 성장 기회와 추천 행동

  • 의료 부문에서 3DP의 성장 기회
  • 3DP 기술 이해관계자의 전략적 필수요건
  • 3DP 약제를 이용한 간질 솔루션 : Aprecia Pharmaceutical

제8장 특허·연락처

제9장 Frost & Sullivan 소개

KSA 17.02.02

Technology that could revolutionize pharmaceutical and biotechnology manufacturing

3D printing (3DP) will have a strong commercial impact across major consumer segments of the global healthcare sectors, an industry that necessitates efficient production of primarily complex or personalized products. The opportunity to customize drugs, active pharmaceutical ingredients (APIs) and medical devices drives an era of personalized medicine. 3D printing has garnered a place on the finisher's podium as one of the highly investigated technologies for potential adoption by a plethora of key participants in the healthcare industry.

Table of Contents

1.0 Executive Summary

  • 1. 1.1 Research Methodology
  • 2. 1.2 Key Findings

2.0 Overview and Definition

  • 1. 2.1 Aspects of 3D Printing versus Traditional Manufacturing
  • 2. 2.2 Crowdsourcing and 3D Printing
  • 3. 2.3 Crowdsourcers Leading the Change
  • 4. 2.4 Mass Customization and 3D Printing

3.0 3D Printing Technology Landscape

  • 1. 3.1 Major 3D Printing Technologies
  • 2. 3.2 Comparative Analysis of 3D Printing Technologies

4.0 Assessment of 3D Printing across Healthcare

  • 1. 4.1 3D Printing has a Dynamic Impact across Multiple Verticals, which Largely Include the Healthcare and Industrial Sectors
  • 2. 4.2 3D Printing Is a Platform for Innovation across Healthcare
  • 3. 4.3 Recent Events across the Healthcare Industry Due to 3D Printing
  • 4. 4.4 Prosthetics, Bone Grafts, and Dental Prosthetics have the Highest Innovation and Adoption rates for 3D Printing Applications
  • 5. 4.5 Prosthetics, Bone Grafts, and Dental Prosthetics with the Highest Innovation and Adoption Rates for 3D Printing Applications
  • 6. 4.6 Prosthetics, Bone Grafts, Ears and Vascular Tissues and Dental Prosthetics with the Highest Innovation and Adoption Rates for 3D Printing Applications
  • 7. 4.7 Prosthetics, Bone Grafts, Ears and Vascular Tissues and Dental Prosthetics with the Highest Innovation and Adoption Rates for 3D Printing Applications

5.0 Competency of 3D Printing across Healthcare

  • 1. 5.1 Business Model of Additive Manufacturing 3D Printer Manufacturers
  • 2. 5.2 Business Model of Additive Manufacturing Material Providers
  • 3. 5.3 Business Model of Additive Manufacturing Service Providers
  • 4. 5.4 Comparative Assessment of 3D Printing Technologies
  • 5. 5.4 Comparative Assessment of 3D Printing Technologies (continued)
  • 6. 5.5 Company Profile - Stratasys
  • 7. 5.6 Stratasys Activities in the Dental Industry - These dental 3D Printers are having a Huge Impact on the Dental Industry
  • 8. 5.7 The Use of Stratasys Printers in the Dental Industry - Case Studies Being used for Various Application in the Dental Industry
  • 9. 5.8 Stratasys Activities in the Healthcare Industry
  • 10. 5.9 The Use of Stratasys Printers in the Healthcare Industry
  • 11. 5.10 Company Profile - 3D Systems
  • 12. 5.11 3D Systems' Activities in the Healthcare Industry
  • 13. 5.12 3D Systems' Printers Used in the Healthcare Industry

6.0 Assessment of Potential Applications - Pharmaceutical

  • 1. 6.1 3D Printing - Key Areas of Impact across the Pharmaceutical Sector
  • 2. 6.2.1 Disease Treatment and Drug Discovery Process: Pharmaceutical Requirement from 3DP
  • 3. 6.2.2 Disease Treatment and Drug Discovery Process: 3DP Impact on Drug Discovery Value Chain
  • 4. 6.2.3 Disease Treatment and Drug Discovery Process: Innovations across Manufacturing Techniques
  • 5. 6.2.4 Disease Treatment and Drug Discovery Process: Impact of Printers across Pharma Innovations
  • 6. 6.2.5 Disease Treatment and Drug Discovery Process: 3D Printing Impact across Pharma Innovations
  • 7. 6.2.6 Disease Treatment and Drug Discovery Process: Tablet Formulation Types and Requirements
  • 8. 6.2.7 Disease Treatment and Drug Discovery Process: Case study - Aprecia Pharmaceuticals
  • 9. 6.3 Company Profile: Aprecia Pharmaceutical
  • 10. 6.3.1 Company Profile: Aprecia Pharmaceutical - Technology/Product
  • 11. 6.4.1 Disease Treatment & Drug Discovery Process - Impact on Drug Screening and Toxicity Testing
  • 12. 6.4.2 Disease Treatment & Drug Discovery Process - Innovation Landscape
  • 13. 6.4.2 Disease Treatment & Drug Discovery Process - Innovation Landscape (continued)
  • 14. 6.4.2 Disease Treatment & Drug Discovery Process - Innovation Landscape (continued)
  • 15. 6.4.3 Disease Treatment & Drug Discovery Process - Case study : Organovo
  • 16. 6.4.4 Disease Treatment & Drug Discovery Process - Innovations in Emerging Markets - India & China
  • 17. 6.5.1 Operational Models of Pharma Business - 3DP a Major Point of Interest for Contract Manufacturers with Pharma Clients
  • 18. 6.5.2 Operational Models of Pharma Business - Impact across Pharmaceutical R&D
  • 19. 6.5.3 Operational Models of Pharma Business - Benefits of 3D Printing Across Pharma Applications
  • 20. 6.5.4 Operational Models of Pharma Business - Current 3DP Implementation Strategies
  • 21. 6.5.5 Operational Models of Pharma Business - Current 3DP Implementation Strategies by Big Pharma
  • 22. 6.6 Drug Supply Chain: How is 3D Printing Interrupting the Drug Supply Chain?
  • 23. 6.7 Impact across Emerging Markets
  • 24. 6.8 Regulatory Landscape
  • 25. 6.9 Drivers and Restraints - Factors Aiding/Hindering Adoption of 3D Printing in the Pharma Industry
  • 26. 6.10 Drivers Explained
  • 27. 6.11 Restraints Explained
  • 28. 6.12 Digital Fabrication's Potential Impact on Drug Accessibility in Emerging Countries
  • 29. 6.13 Strategic Recommendations on Steps Forward

7.0 Growth Opportunities and Companies to Action

  • 1. 7.1 Growth Opportunity: 3D Printing for Healthcare
  • 2. 7.2 Major Growth Opportunities for 3DP in Healthcare
  • 3. 7.3 Strategic Imperatives for 3DP Technology Stakeholders
  • 4. 7.4 Epileptic Solutions Using 3D Printed Drugs - Aprecia Pharmaceutical, US

8.0 Patent Landscape Overview & Key Contacts

  • 1. 8.1 Patent Search Scope
  • 2. 8.2 Patent Publishing Trends, Global, 2011-2015
  • 3. 8.3 Top 20 Patent holders, Global, 2010-2015
  • 4. 8.4 Patents per Source Jurisdiction (Top 10 Patent offices), Global, 2010-2015
  • 5. 8.5 Key Company Contacts
  • 6. Legal Disclaimer

9.0 The Frost & Sullivan Story

  • 1. 9.1 The Frost & Sullivan Story
  • 2. 9.2 Value Proposition: Future of Your Company & Career
  • 3. 9.3 Global Perspective
  • 4. 9.4 Industry Convergence
  • 5. 9.5 360° Research Perspective
  • 6. 9.6 Implementation Excellence
  • 7. 9.7 Our Blue Ocean Strategy
Back to Top
전화 문의
F A Q